IBSA PHARMA INC recalls TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for…

Recall date

January 30, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0334-2023

FDA classification

Class II

Brand / firm

IBSA PHARMA INC

Sold / distributed

Nationwide in the USA.

Why it was recalled

Subpotent Drug

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0155-5